Antiviral small molecules that inhibited cathepsin L were able to inhibit SARS-CoV infections in vitro and that of other viruses that depend on cathepsin L for entry, such as Ebola, Hendra, and Nipah viruses [50]. Here, CTSL is linked to severe acute respiratory syndrome.